Skip to main content
EN
Caution:
At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
Patent Search
Details
Details for 2022174931
Up to date per 07.06.2026
Actions
Copy link to European Patent
Download Registration Print
Details
Details for 2022174931
Title / Product Name
PEGYLIERTE LIPOSOMEN ZUR AUSLIEFERUNG VON IMMUNOGEN-KODIERENDER RNS
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2022174931
EP Publication Number
4066856
E-Number
1535895
Language
EN
PCT Number
Publication Date
05.10.2022 A
07.12.2022 B1
Registration Date
07.12.2022
AT Publication Date
15.12.2022
Application Date
31.08.2011
Registration Number
-
Priorities
31.08.2010
US
37882610 P
IPC
A61K 39/39 20060101AFI20220901BHEP
Maximum Duration of Protection
31.08.2031
Owner
GlaxoSmithKline Biologicals SA
Rue de l'Institut, 89
1330 Rixensart
BE
Representative
Representative
Schwarz & Partner Patentanwälte GmbH
Wipplingerstraße 30
1010 Wien
AT
Inventor
GEALL, Andrew
Emeryville, 94662-8097
US
VERMA, Ayush
Emeryville, 94662-8097
US
Information about Fees
Click here to load the fees